Overview

Pneumococcal Vaccine Market is poised to value USD 10722 million by 2028 end at a CAGR of 4.6% during the forecast period 2022 to 2028.

Infections include middle ear infections, blood infections, pneumonia, and bacterial meningitis are all part of the widespread and frequently mild pneumococcal illness. The illness, however, occasionally brings about serious and grave health issues. The causal agent of pneumococcal pneumonia, streptococcus pneumonia, is protected against by pneumococcal vaccinations. Conjugate vaccination and polysaccharide vaccine are the two forms of vaccine that are offered. The intramuscular method is used to give pneumococcal vaccinations. While polysaccharide vaccinations are beneficial in healthy adults, conjugate vaccines are given to infants. To avoid infection from the streptococcus pneumoniae bacteria, pneumococcal vaccination is utilised. There are two different pneumococcal vaccines: the polysaccharide vaccine and the conjugate vaccine. For individuals of various ages experiencing various infections and past disorders, there are distinct directions and dosages. One of the key factors propelling the growth of the pneumococcal vaccine market is the rise in the number of pneumonia cases around the world. The increased demand for specialised medications to treat disease-related consequences like breathing problems and the increase in funding provided to researchers to create novel interventions or treatments both contribute to the market's rapid expansion. The market is also impacted by an increase in the launch of innovative pneumococcal vaccines, rising government spending, and increased health-awareness initiatives. Additionally, the market for pneumococcal vaccines is positively impacted by technological advancement, an increase in healthcare spending, population expansion, and special regulatory designation. The market for pneumococcal vaccinations is anticipated to have an increase in overall revenue during the forecast period as a consequence of rising efforts by numerous nations to offer such vaccines in conjunction with funding programmes.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pneumococcal Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis,market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.

According to the research study conducted by FutureWise research analysts, the Pneumococcal Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the Pneumococcal Vaccine Market along with the growth opportunities present across this business vertical.

Major players included in the Pneumococcal Vaccine Market are :

• Merck & Co., Inc.
• Pfizer Inc.
• GlaxoSmithKline plc.
• Sanofi Pasteur
• China National Biotec Group
• Astellas Pharma Inc
• Serum Institute of India Pvt. Ltd.
• GAVI
• Panacea Biotec
• Aurobindo Pharma
(Note: The list of the major players will be updated with the latest market scenario and trends)

Pneumococcal Vaccine Market Segmentation:

By Vaccine Type
• Penumococcal Conjugate Vaccine
• Pneumococcal Polysaccharide Vaccine
By Dosage
• Single Dose Vial
• Pre-Filled Syringe
By End-User
• Children aged 2 to 10
• Adulst aged 10  to 64
• Geriatric aged more than 65
By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa


Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants


FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth


Objectives of the Study:

• To provide with an exhaustive analysis on the Pneumococcal Vaccine Market By Vaccine Type, By Dosage, By End-User and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions


Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics